| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/21/2010 | US20100015220 Niacin and nsaid combination therapy |
| 01/21/2010 | US20100015219 Pharmaceutical compositions of active substances difficult to improperly divert from their intended route of administration |
| 01/21/2010 | US20100015218 Compositions and methods for potentiated activity of biologically active molecules |
| 01/21/2010 | US20100015217 Enhancing Pulmonary Host Defense via Administration of Granulocyte-Macrophage Colony Stimulating Factor |
| 01/21/2010 | US20100015216 Methods and materials for treating acne |
| 01/21/2010 | US20100015215 Use of Glycolipids as Adjuvants |
| 01/21/2010 | US20100015214 Novel Trans-Adjuvant System |
| 01/21/2010 | US20100015213 Compositions and Methods Using Same for Delivering Agents Into a Target Organ Protected by a Blood Barrier |
| 01/21/2010 | US20100015212 Immunogenic bacterial vesicles with outer membrane proteins |
| 01/21/2010 | US20100015211 Combination Approaches For Generating Immune Responses |
| 01/21/2010 | US20100015210 Patch and patch preparation |
| 01/21/2010 | US20100015209 Patch and patch preparation |
| 01/21/2010 | US20100015208 Antibacterial wound dressing |
| 01/21/2010 | US20100015207 Methods for Treating Oral Cavity Infections with Chlorine Dioxide |
| 01/21/2010 | US20100015197 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 01/21/2010 | US20100015196 Drug Depot Implantable Within a Joint |
| 01/21/2010 | US20100015195 Injectable depot compositions and it's process of preparation |
| 01/21/2010 | US20100015192 Hydrocolloid carrier beads with inert filler material |
| 01/21/2010 | US20100015190 Preparation for reducing and/or preventing body fat and respective uses, in particular together with a dressing material |
| 01/21/2010 | US20100015185 Biodegradable material based on opened starch |
| 01/21/2010 | US20100015184 Methods of Making Pharmaceutical Components for Customized Drug Products |
| 01/21/2010 | US20100015183 Transmucosal delivery devices with enhanced uptake |
| 01/21/2010 | US20100015065 Compositions for food, process for producing the same, and functional foods and drinks containing the same |
| 01/21/2010 | US20100015064 Foamable composition for killing arthropods and uses thereof |
| 01/21/2010 | US20100015063 Benzodiazepine Derivatives and Pharmaceutical Compositions Containing Them |
| 01/21/2010 | US20100015062 Method of treating pulmonary disease with interferons |
| 01/21/2010 | US20100015061 Pharmaceutical Compositions Based on Anticholinergics and Andolast |
| 01/21/2010 | US20100012118 Medicament dosage for inhaler |
| 01/21/2010 | US20100012114 Particle-size reduction apparatus, and use thereof |
| 01/21/2010 | DE102008033327A1 Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik Silica material with at least one therapeutically active agent for the preparation of biologically degradable and / or resorbable silica gel materials for human medicine and / or medical |
| 01/21/2010 | CA2730897A1 Phosphopeptides and use of the same |
| 01/21/2010 | CA2730847A1 Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| 01/21/2010 | CA2730806A1 Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic |
| 01/21/2010 | CA2730796A1 Aptamer against il-17 and use thereof |
| 01/21/2010 | CA2730787A1 Topical drug delivery system |
| 01/21/2010 | CA2730752A1 Method of manufacturing cellular films directly |
| 01/21/2010 | CA2730745A1 Long-acting injectable analgesic formulations for animals |
| 01/21/2010 | CA2730737A1 Immunogenic amphipathic peptide compositions |
| 01/21/2010 | CA2730697A1 Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology |
| 01/21/2010 | CA2730694A1 Silicon dioxide nanoparticles and the use thereof for vaccination |
| 01/21/2010 | CA2730665A1 Dosage form containing a statin |
| 01/21/2010 | CA2730534A1 Formulation for improving the bioavailability of a hydrophobic molecule |
| 01/21/2010 | CA2730218A1 Method for manufacturing medicinal compounds containing dabigatran |
| 01/21/2010 | CA2729644A1 Process for improving crystallinity |
| 01/21/2010 | CA2689472A1 Articles of manufacture releasing an active ingredient |
| 01/20/2010 | EP2145743A2 Process for producing adhesive patch |
| 01/20/2010 | EP2145629A2 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 01/20/2010 | EP2145628A1 Treatment of neurodegenerative disease through intracranial delivery of short interfering RNA (siRNA) |
| 01/20/2010 | EP2145618A1 Retinoid solutions and formulations made thereform |
| 01/20/2010 | EP2145617A1 Gel formulation |
| 01/20/2010 | EP2144896A1 Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same |
| 01/20/2010 | EP2144697A2 Process for encapsulating chemically active substances and encapsulated product |
| 01/20/2010 | EP2144625A1 A controlled release enzymatic composition and methods of use |
| 01/20/2010 | EP2144610A1 Melatonin tablet and methods of preparation and use |
| 01/20/2010 | EP2144608A1 Sunscreen compositions and methods |
| 01/20/2010 | EP2144601A2 Rapidly dissolving pharmaceutical compositions comprising pullulan |
| 01/20/2010 | EP2144600A2 Poly (amino acid) targeting moieties |
| 01/20/2010 | EP2144599A2 Sustained release pellets comprising wax-like material |
| 01/20/2010 | EP2144598A2 Precipitation stabilising compositions |
| 01/20/2010 | EP2144590A1 Skin treatment compositions and methods |
| 01/20/2010 | EP2032123B1 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
| 01/20/2010 | EP1686964B1 Microparticles comprising somatostatin analogues |
| 01/20/2010 | EP1663191B1 Composition comprising rosiglitazone and metformin |
| 01/20/2010 | EP1474114B1 Oral dosage form for controlled drug release |
| 01/20/2010 | EP1427396B1 Dosage forms having prolonged active ingredient release |
| 01/20/2010 | EP1418951B1 Transdermal therapeutic system (tts) with fentanyl as active ingredient |
| 01/20/2010 | EP1390866B1 Container and method for dispensing transdermal dosage forms |
| 01/20/2010 | EP1313422B1 Non-hormonal vaginal contraceptive |
| 01/20/2010 | EP1267880B2 Low dose entecavir formulation and use |
| 01/20/2010 | EP1028708B1 Topical compositions for prostaglandin e1 delivery |
| 01/20/2010 | CN201384713Y Piperazine ferulate enteric-coated tablet |
| 01/20/2010 | CN201384712Y Sodium ferulate enteric-coated tablet |
| 01/20/2010 | CN201384622Y Universal ointment for curing sores |
| 01/20/2010 | CN101631537A Patch for cutaneous application |
| 01/20/2010 | CN101631536A Tablet-in-tablet compositions |
| 01/20/2010 | CN101631535A High protein concentration formulations containing mannitol |
| 01/20/2010 | CN101631534A Galenic form for the transmucosal delivery of paracetamol |
| 01/20/2010 | CN101631533A Controlled release preparation containing cilostazoland process for the preparation thereof |
| 01/20/2010 | CN101628933A HIV peptides from tat, rev and wef conserved and their application as e.g. vaccine components |
| 01/20/2010 | CN101627981A Patch and patch preparation |
| 01/20/2010 | CN101627980A Patch and patch preparation |
| 01/20/2010 | CN101627979A Estradiol transdermal slow-release paster |
| 01/20/2010 | CN101627978A Glipizide sustained-release capsule formulation and preparation method thereof |
| 01/20/2010 | CN101627977A Double-layer osmotic pump controlled-release medicinal composition of barnidipine or physiologically acceptable salt of barnidipine |
| 01/20/2010 | CN101627976A Felodipine sustained-release preparation and preparation method thereof |
| 01/20/2010 | CN101627975A Barnidipine slow release preparation and method for preparing same |
| 01/20/2010 | CN101627974A Once-a-day oxycodone formulations |
| 01/20/2010 | CN101627973A Calcium acetate tablet and preparation method thereof |
| 01/20/2010 | CN101627972A Entecavir orally disintegrating tablet and method for preparing same |
| 01/20/2010 | CN101627971A Nanocrystallized mitiginide calcium hydrate orally disintegrating tablet and preparation method thereof |
| 01/20/2010 | CN101627970A Method for preparing medicinal solid lipid nano particle |
| 01/20/2010 | CN101627969A Novel curcumin self-emulsifying drug delivery system and preparation method thereof |
| 01/20/2010 | CN101627968A Preparation method of alprostadil injection |
| 01/20/2010 | CN101627967A Ambroxol hydrochloride liquid preparation and preparation method thereof |
| 01/20/2010 | CN101627966A Method for preparing Alarelin sustained-release microspheres injection |
| 01/20/2010 | CN100582774C Detection method of treating prostatitis formulation |
| 01/20/2010 | CN100582771C Chinese medicinal soft capsule effective ingredient detection method |
| 01/20/2010 | CN100582169C Particle-stabilised emulsions |
| 01/20/2010 | CN100582130C Novel temperature and PH sensitive copolymers |
| 01/20/2010 | CN100582122C O-type foot-and-mouth disease virus multi-epitope mucous membrane immunization vaccine and use |